Renal Denervation Devices Market by Technology (Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based), Products (Catheters, Multi Electrode Catheter, Nerve Modifying Agents), Disease Application, End-User - Global Forecast 2023-2030

Renal Denervation Devices Market by Technology (Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based), Products (Catheters, Multi Electrode Catheter, Nerve Modifying Agents), Disease Application, End-User - Global Forecast 2023-2030


The Renal Denervation Devices Market size was estimated at USD 296.12 million in 2022 and expected to reach USD 400.34 million in 2023, at a CAGR 35.67% to reach USD 3,400.46 million by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Renal Denervation Devices Market.
  • Based on Technology, market is studied across Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based, and Ultrasound-Based. The Pharmacologic Ablation is projected to witness significant market share during forecast period.
  • Based on Products, market is studied across Catheters, Multi Electrode Catheter, Nerve Modifying Agents, RF Generator, and Single Electrode Catheter. The RF Generator is projected to witness significant market share during forecast period.
  • Based on Disease Application, market is studied across Diabetes, Heart Failure, Hypertension, and Renal Failure. The Renal Failure is projected to witness significant market share during forecast period.
  • Based on End-User, market is studied across Ambulatory Care Centers, Diagnostic Centers & Hospitals, and Research & Academia. The Diagnostic Centers & Hospitals is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Renal Denervation Devices Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Renal Denervation Devices Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Renal Denervation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., Boston Scientific Corporation, Cordis Corporation, Medtronic PLC, Mercator Medsystems, Inc., Otsuka Medical Devices Co., Ltd., Recor Medical, Inc., SoniVie Ltd., Symple Surgical, Inc., and Terumo Corporation.

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Renal Denervation Devices Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Renal Denervation Devices Market?
  3. What is the competitive strategic window for identifying opportunities in the Renal Denervation Devices Market?
  4. What are the latest technology trends and regulatory frameworks in the Renal Denervation Devices Market?
  5. What is the market share of the leading vendors in the Renal Denervation Devices Market?
  6. Which modes and strategic moves are suitable for entering the Renal Denervation Devices Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Renal Denervation Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of congestive heart failure, diabetes, and chronic renal failure
5.1.1.2. Growing adoption of minimally invasive surgical procedures
5.1.1.3. Increasing geriatric population with resistant hypertension
5.1.2. Restraints
5.1.2.1. Limited efficacy of renewal denervation devices
5.1.3. Opportunities
5.1.3.1. Emergence of state-of-art RDN devices
5.1.3.2. Favorable reimbursement policies
5.1.4. Challenges
5.1.4.1. Lack of trained and experienced healthcare professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Renal Denervation Devices Market, by Technology
6.1. Introduction
6.2. Micro-Infusion-Based
6.3. Pharmacologic Ablation
6.4. Radiofrequency-Based
6.5. Ultrasound-Based
7. Renal Denervation Devices Market, by Products
7.1. Introduction
7.2. Catheters
7.3. Multi Electrode Catheter
7.4. Nerve Modifying Agents
7.5. RF Generator
7.6. Single Electrode Catheter
8. Renal Denervation Devices Market, by Disease Application
8.1. Introduction
8.2. Diabetes
8.3. Heart Failure
8.4. Hypertension
8.5. Renal Failure
9. Renal Denervation Devices Market, by End-User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Diagnostic Centers & Hospitals
9.4. Research & Academia
10. Americas Renal Denervation Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Renal Denervation Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Renal Denervation Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Ablative Solutions, Inc.
14.1.3. Boston Scientific Corporation
14.1.4. Cordis Corporation
14.1.5. Medtronic PLC
14.1.6. Mercator Medsystems, Inc.
14.1.7. Otsuka Medical Devices Co., Ltd.
14.1.8. Recor Medical, Inc.
14.1.9. SoniVie Ltd.
14.1.10. Symple Surgical, Inc.
14.1.11. Terumo Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings